MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment
Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial, recommending continued progression as planned MRX-4 Injection followed by Contezolid Tablets demonstrated favorable safety...
Lessons from Japan's AMR Response for the Global Community
https://iris.who.int/handle/10665/380481 TOKYO, Feb. 25, 2025 /PRNewswire/ -- World Health Organization (WHO) Regional Office for the Western Pacific (WPRO) has released Japan's AMR Response 2013–2025 alongside Tokyo AMR One Health Conference...
Bybit Defies Odds: How the Largest Crypto Hack in History Became a Test of Resilience and Transparency
DUBAI, UAE, Feb. 23, 2025 /PRNewswire/ -- In a remarkable display of resilience and professionalism, Bybit, the world's second-largest cryptocurrency exchange by trading volume, has successfully navigated the largest hack in crypto history. On...
Silicon Quantum Computing achieves world-leading accuracy of Grover's algorithm without error correction
SYDNEY, Feb. 20, 2025 /PRNewswire/ -- Silicon Quantum Computing (SQC), a pioneer in quantum computing and atomic manufacturing, today announced that it has demonstrated world-leading accuracy in the operation of Grover's algorithm without error...
Unilumin Wins Inavation Awards at ISE 2025 | A Testament to Global Leadership
BARCELONA, Spain, Feb. 10, 2025 /PRNewswire/ -- At ISE 2025 in Barcelona, Unilumin Group once again demonstrated its industry leadership by winning the prestigious Inavation Awards for its Upanel II MIP. As one of the AV industry's most influential...
MEDCOENERGI IMPROVES MSCI ESG RATING TO "AA"
JAKARTA, Indonesia, Feb. 5, 2025 /PRNewswire/ -- PT Medco Energi Internasional Tbk (MedcoEnergi) has received an upgrade to its MSCI ESG rating, from "A" to "AA". This recognition positions MedcoEnergi as a leader in sustainability within the...
Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins
GOTHENBURG, Sweden, Jan. 28, 2025 /PRNewswire/ -- "In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all...
Seeking Investors: First-in-Class Immunotherapeutics for Cancer
ATLANTA, Jan. 27, 2025 /PRNewswire/ -- Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical studies. The drug is mutation-agnostic, and the...
Hyundai MOBIS moves forward with its new 'Move Improved' campaign
With a tagline 'Move Improved', advanced mobility technologies are introduced in a joyful and relatable story of driving experience. Through social media launch, it aims to create a better understanding of the Hyundai MOBIS' brand and its mobility...
Lunit AI Enhances Precision in Predicting Outcomes for HER2-Targeted Therapy in Metastatic Colorectal Cancer - new study published in JCO Precision Oncology
Newly published study in collaboration with Japan's NCCHE reveals how AI-powered HER2 and tumor microenvironment analysis improves patient stratification and clinical outcome predictions SEOUL, South Korea, Jan. 23, 2025 /PRNewswire/ -- Lunit...